Pricing

Statera BioPharma Inc (STAB)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael K. Handley
Employees:
20
2537 RESEARCH BOULEVARD, SUITE 201, FORT COLLINS, CO, 80526
(888) 613-8802
Stock Split History
DateRatio
2015-01-28 1:20
Statera BioPharma, Inc. develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (Stat-401), and COVID-19 (stat-205) as well as expanding into fibromyalgia and multiple sclerosis.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available